Corticospinal Tract Development in Intrauterine Growth Restriction
宫内生长受限时皮质脊髓束的发育
基本信息
- 批准号:10672052
- 负责人:
- 金额:$ 12.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-27 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary
Infants born following intrauterine growth restriction (IUGR) are at risk for the development of cerebral
palsy (CP). However, it is not precisely understood how perinatal neurologic injury due to IUGR results in
motor dysfunction. Using a novel thromboxane A2 (TXA2) murine model of IUGR, we have previously
demonstrated significant downregulation of major myelin genes (MoBP, PLP1, CNPase, MOG) in whole brain,
decreased corticospinal tract (CST) volume in the brain, and impaired gait. The most profound injury occurred
when IUGR was combined with postnatal hyperoxia exposure, suggesting a “double hit” mechanism. These
findings support a model in which transcriptional changes occur after IUGR that alter oligodendrocytes (OL)
making them more susceptible to hyperoxia. Our findings lead us to the central hypothesis that IUGR with
postnatal hyperoxia results in cell specific changes to the OL transcriptome that lead to pathologic changes to
the CST and motor deficits seen in CP. In Aim 1, in vivo genetic and biochemical methods will be employed in
this model to determine how IUGR/postnatal hyperoxia change the OL transcriptome. This aim will add further
understanding to the underlying causes of white matter (WM) injury after IUGR. As CST is known to be
disturbed in spastic CP, the most common type of CP in perinatal brain injury, Aim 2 will evaluate CST
development using advanced in vivo imaging techniques to demonstrate how IUGR/postnatal hyperoxia alter
development of descending motor tracts in the spinal cord. In Aim 3, altered motor input resulting in distal limb
movement abnormalities and increased hyperreflexia/ spasms will be quantified using novel motor tests. The
innovative motor testing employed in this aim will provide the means to rigorously quantify motor dysfunction
resulting from our injury model and compare it to motor dysfunction seen in CP.
This study will impact the field by 1) providing insight into specific changes to the OL transcriptome
leading to abnormal myelination and CST development and 2) expanding the understanding of the
development of the CP phenotype in IUGR. This study is significant because of its quantitative approach to
imaging modalities and motor assessments that can be applied more broadly to other murine models of
perinatal brain injury and provide a basis for investigating novel therapeutic interventions in humans. Finally,
this study will provide an excellent vehicle for the applicant to develop into an independent investigator.
Investigations will be performed in an environment with an established history of successful mentorship of
junior faculty to independence. With the support of this application, the applicant will 1) advance her technical
skills (RiboTag RNA isolation, next generation sequencing, murine MRI, electromyography and kinematic
testing techniques) and 2) learn advanced biostatistics. Future independent studies will focus on the interplay
between pathways altered by IUGR/hyperoxia in WM development and potential therapeutic interventions that
can be directly tested in the murine models and ultimately neonatal patients.
项目摘要
胎儿宫内生长受限(IUGR)后出生的婴儿有脑发育的风险,
麻痹(CP)。然而,由于IUGR引起的围产期神经系统损伤如何导致
运动功能障碍使用一种新的血栓素A2(TXA 2)IUGR小鼠模型,我们以前
证明了全脑主要髓鞘基因(MoBP、PLP 1、CNBP、MOG)的显著下调,
大脑皮质脊髓束(CST)体积减少,步态受损。最严重的伤害发生在
当IUGR与出生后高氧暴露相结合时,提示“双重打击”机制。这些
研究结果支持了一个模型,即IUGR后发生的转录变化改变了少突胶质细胞(OL)
使他们更容易受到高氧的影响。我们的研究结果使我们的核心假设,即IUGR与
出生后高氧导致OL转录组的细胞特异性变化,导致病理变化,
在CP中观察到的CST和运动缺陷。在目标1中,将采用体内遗传和生物化学方法,
该模型用于确定IUGR/出生后高氧如何改变OL转录组。这一目标将进一步增加
了解IUGR后白色物质(WM)损伤的根本原因。众所周知,CST
痉挛性CP是围产期脑损伤中最常见的CP类型,目的2将评估CST
使用先进的体内成像技术来证明IUGR/出生后高氧如何改变
脊髓中下行运动束的发育。在目标3中,运动输入改变导致远端肢体
运动异常和反射亢进/痉挛的增加将使用新的运动测试来量化。的
在这一目标中采用的创新运动测试将提供严格量化运动功能障碍的手段
并将其与CP中观察到的运动功能障碍进行比较。
这项研究将通过以下方式影响该领域:1)深入了解OL转录组的特定变化
导致髓鞘形成和CST发育异常; 2)扩大对
IUGR中CP表型的发展。这项研究是有意义的,因为它的定量方法,
成像模式和运动评估,可以更广泛地应用于其他鼠模型,
围产期脑损伤,并为研究人类新的治疗干预措施提供基础。最后,
这项研究将为申请人发展成为独立调查员提供一个极好的工具。
调查将在一个具有成功指导历史的环境中进行,
初级教师走向独立。在本申请的支持下,申请人将1)提高其技术水平,
技能(RiboTag RNA分离,下一代测序,小鼠MRI,肌电图和运动学
测试技术)和2)学习先进的生物统计学。未来的独立研究将集中在相互作用
WM发展中IUGR/高氧改变的途径与潜在的治疗干预措施之间的关系,
可以直接在小鼠模型和最终的新生儿患者中进行测试。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jill Chang其他文献
Jill Chang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jill Chang', 18)}}的其他基金
Corticospinal Tract Development in Intrauterine Growth Restriction
宫内生长受限时皮质脊髓束的发育
- 批准号:
10591594 - 财政年份:2020
- 资助金额:
$ 12.74万 - 项目类别:
Corticospinal Tract Development in Intrauterine Growth Restriction
宫内生长受限时皮质脊髓束的发育
- 批准号:
10396506 - 财政年份:2020
- 资助金额:
$ 12.74万 - 项目类别:
相似海外基金
Development of bile cell block specimens for enabling comprehensive genome profiling and therapeutic medicine discovery of bile tract cancer
开发胆细胞块样本,以实现胆道癌的全面基因组分析和治疗药物发现
- 批准号:
23K14646 - 财政年份:2023
- 资助金额:
$ 12.74万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
SBIR Phase II: Development of a urine dipstick test that can guide immediate and appropriate antibiotic therapy for treatment of complicated urinary tract infections
SBIR II 期:开发尿液试纸测试,可以指导复杂尿路感染的立即和适当的抗生素治疗
- 批准号:
2213034 - 财政年份:2023
- 资助金额:
$ 12.74万 - 项目类别:
Cooperative Agreement
Development, Function, and Dysfunction of Gastrointestinal Tract-Innervating Dorsal Root Ganglia Neurons in Autism Spectrum Disorder
自闭症谱系障碍中胃肠道支配的背根神经节神经元的发育、功能和功能障碍
- 批准号:
10584142 - 财政年份:2023
- 资助金额:
$ 12.74万 - 项目类别:
Development of a novel needle tract sealant system for pneumothorax prevention duringlung biopsy
开发一种新型针道密封剂系统,用于肺活检期间预防气胸
- 批准号:
10035983 - 财政年份:2022
- 资助金额:
$ 12.74万 - 项目类别:
EU-Funded
Development of urinary tract reconstruction without suturing
无缝合尿路重建技术的进展
- 批准号:
22K09456 - 财政年份:2022
- 资助金额:
$ 12.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of PBBM Framework to Support an Assessment of Bioequivalence for Locally-Acting Drugs in the Gastrointestinal Tract in Healthy Subjects and Patients
开发 PBBM 框架以支持健康受试者和患者胃肠道局部作用药物的生物等效性评估
- 批准号:
10701033 - 财政年份:2022
- 资助金额:
$ 12.74万 - 项目类别:
Development of PBBM Framework to Support an Assessment of Bioequivalence for Locally-Acting Drugs in the Gastrointestinal Tract in Healthy Subjects and Patients
开发 PBBM 框架以支持健康受试者和患者胃肠道局部作用药物的生物等效性评估
- 批准号:
10599520 - 财政年份:2022
- 资助金额:
$ 12.74万 - 项目类别:
Understanding the role of GATA transcription factors in lower urinary tract development using a compound chimaeric approach.
使用复合嵌合方法了解 GATA 转录因子在下尿路发育中的作用。
- 批准号:
22K06256 - 财政年份:2022
- 资助金额:
$ 12.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development and verification of in vitro integrated mechanistic population-based PBPK model framework towards virtual bioequivalence assessment of locally acting drug products in the GI tract
开发和验证基于体外综合机械群体的 PBPK 模型框架,以对胃肠道中局部作用的药物产品进行虚拟生物等效性评估
- 批准号:
10709607 - 财政年份:2022
- 资助金额:
$ 12.74万 - 项目类别:
Disease-specific comprehensive pathogenesis of male lower urinary tract dysfunction and development of innovative therapies
男性下尿路功能障碍的疾病特异性综合发病机制及创新疗法的开发
- 批准号:
22H03216 - 财政年份:2022
- 资助金额:
$ 12.74万 - 项目类别:
Grant-in-Aid for Scientific Research (B)